These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9935166

  • 1. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression.
    Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S.
    Int J Cancer; 1999 Feb 09; 80(4):617-23. PubMed ID: 9935166
    [Abstract] [Full Text] [Related]

  • 2. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 09; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway.
    Graham CH, Fitzpatrick TE, McCrae KR.
    Blood; 1998 May 01; 91(9):3300-7. PubMed ID: 9558386
    [Abstract] [Full Text] [Related]

  • 4. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D, Berger DH, Rothman VL, Tuszynski GP.
    J Surg Res; 1999 Apr 01; 82(2):331-8. PubMed ID: 10090848
    [Abstract] [Full Text] [Related]

  • 5. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.
    J Pathol; 2008 Apr 01; 214(5):545-54. PubMed ID: 18189329
    [Abstract] [Full Text] [Related]

  • 6. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS, Kwaan HC, Svoboda KM, Weiss IM, Sakurai S, Jordan VC.
    Br J Cancer; 1998 Jul 01; 78(1):88-95. PubMed ID: 9662256
    [Abstract] [Full Text] [Related]

  • 7. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S, New L, Pan Z, Han J, Nemerow GR.
    J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865
    [Abstract] [Full Text] [Related]

  • 8. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
    Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ.
    Cancer Biol Ther; 2005 Apr 21; 4(4):400-6. PubMed ID: 15846059
    [Abstract] [Full Text] [Related]

  • 9. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C, Yu J, Huang S.
    Mol Carcinog; 2007 Mar 21; 46(3):165-75. PubMed ID: 17186542
    [Abstract] [Full Text] [Related]

  • 10. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
    Yoon SY, Lee YJ, Seo JH, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Cell Res; 2006 Jan 21; 16(1):75-81. PubMed ID: 16467878
    [Abstract] [Full Text] [Related]

  • 11. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R, Gondi CS, Lakka SS, Jutla A, Rao JS.
    Int J Oncol; 2006 Apr 21; 28(4):831-9. PubMed ID: 16525631
    [Abstract] [Full Text] [Related]

  • 12. In vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells.
    Luparello C, Del Rosso M.
    Eur J Cancer; 1996 Apr 21; 32A(4):702-7. PubMed ID: 8695276
    [Abstract] [Full Text] [Related]

  • 13. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
    Khatib AM, Nip J, Fallavollita L, Lehmann M, Jensen G, Brodt P.
    Int J Cancer; 2001 Feb 01; 91(3):300-8. PubMed ID: 11169951
    [Abstract] [Full Text] [Related]

  • 14. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F, Jia S, Xing G, Gao L, Zhang L, He F.
    DNA Cell Biol; 2001 May 01; 20(5):297-305. PubMed ID: 11410166
    [Abstract] [Full Text] [Related]

  • 15. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.
    Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ.
    Int J Cancer; 1995 May 29; 61(5):597-600. PubMed ID: 7768629
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 17. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
    Abe J, Urano T, Konno H, Erhan Y, Tanaka T, Nishino N, Takada A, Nakamura S.
    Cancer; 1999 Dec 15; 86(12):2602-11. PubMed ID: 10594855
    [Abstract] [Full Text] [Related]

  • 18. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

  • 19. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T.
    Int J Cancer; 2002 Dec 01; 102(4):379-89. PubMed ID: 12402308
    [Abstract] [Full Text] [Related]

  • 20. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N, Mattiello A, Mancini A, Taglialatela P, Caputi M, Rossi G, Ragno P.
    Int J Cancer; 2003 Jun 20; 105(3):353-60. PubMed ID: 12704669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.